{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:38:21Z","timestamp":1790221101207,"version":"4.1.0"},"reference-count":28,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>Background: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease and is associated with various co-morbidities. Transient elastography (FibroScan\u00ae) is a non-invasive method to detect NAFLD using the controlled attenuation parameter (CAP). We aimed to evaluate the association of the lipid panel and aminotransferases concentrations with the presence or absence of steatosis and fibrosis. Methods: One hundred and five patients with NAFLD were included. Hepatic steatosis was quantified by CAP (dB\/m) and liver stiffness by Kilopascals (kPa), these values were then analyzed against patient lipid panel and serum concentrations of the liver enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT). A correlation and multiple regression were used. Mann-Whitney U test was used as non-parametric analysis. Results: We observed an association between hepatic steatosis and total cholesterol (B = 0.021, p = 0.038, Exp (B) = 1.021, I.C = 1.001-1.041) as well as serum triglycerides (B = 0.017, p = 0.006, Exp (B) = 1.018 and I.C = 1.005-1.030). Similarly, we found an association between significant hepatic fibrosis and lower concentrations of total cholesterol (B = -0.019, p = 0.005, Exp (B) = 0.982 I.C = 0.969-0.995) and elevated AST (B = 0.042, p = 3.25 \u00d7 10-4, Exp (B) = 1.043 I.C = 1.019-1.068) independent of age, gender and BMI. Conclusions: Our results suggest that, total cholesterol and triglyceride concentrations positively correlate with hepatic steatosis while significant hepatic fibrosis is associated with lower total cholesterol and higher AST concentrations.<\/jats:p>","DOI":"10.5937\/jomb0-24689","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T12:58:14Z","timestamp":1588165094000},"page":"60-66","source":"Crossref","is-referenced-by-count":13,"title":["Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan\u00ae)"],"prefix":"10.5937","volume":"40","author":[{"suffix":"Alberto","given":"Luis","family":"Chi-Cervera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Iaarah","given":"Gordon","family":"Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Eugenia","given":"Mar\u00eda","family":"Icaza-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Torres-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Arana-Arg\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ram\u00edrez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Lara-Riegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature reviews Gastroenterology & Hepatology 2018; 15(1): 11-20.;","DOI":"10.1038\/nrgastro.2017.109"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. The New England Journal of Medicine 2010; 362(18): 1675-85.;","DOI":"10.1056\/NEJMoa0907929"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Angulo P. Nonalcoholic fatty liver disease. The New England Journal of Medicine 2002; 346(16): 1221-31.;","DOI":"10.1056\/NEJMra011775"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proceedings of the National Academy of Sciences of the United States of America 2009; 106(36): 15430-5.;","DOI":"10.1073\/pnas.0904944106"},{"key":"ref5","unstructured":"Nassir F, Rector RS, Hammoud GM, Ibdah JA. Pathogenesis and Prevention of Hepatic Steatosis. Gastroenterology & Hepatology 2015; 11(3): 167-75.;"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan\u00ae) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World Journal of Gastroenterology 2016; 22(32): 7236-51.;","DOI":"10.3748\/wjg.v22.i32.7236"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver international: official journal of the International Association for the Study of the Liver 2014; 34(1): 102-9.;","DOI":"10.1111\/liv.12282"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clinics and research in hepatology and gastroenterology. 2012; 36(1): 13-20.;","DOI":"10.1016\/j.clinre.2011.08.001"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51(2): 454-62.;","DOI":"10.1002\/hep.23312"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Friedrich-Rust M, Hadji-Hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, et al. Transient elastography with a new probe for obese patients for non-invasive staging of nonalcoholic steatohepatitis. European Radiology 2010; 20(10): 2390-6.;","DOI":"10.1007\/s00330-010-1820-9"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kim SU, Ahn SH, Park JY, Kang W, Kim DY, Park YN, et al. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. Journal of Clinical Gastroenterology 2009; 43(3): 267-71.;","DOI":"10.1097\/MCG.0b013e31816f212e"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. Journal of Hepatology 2008; 48(5): 835-47.;","DOI":"10.1016\/j.jhep.2008.02.008"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Yoneda M, Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, et al. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56(9): 1330-1.;","DOI":"10.1136\/gut.2007.126417"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2001; 98(13): 7522-7.;","DOI":"10.1073\/pnas.121164498"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013; 5(5): 1544-60.;","DOI":"10.3390\/nu5051544"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease. Journal of Clinical Investigation 2005; 115(5): 1343-51.;","DOI":"10.1172\/JCI23621"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. Journal of Hepatology 2018; 68(2): 280-95.;","DOI":"10.1016\/j.jhep.2017.11.014"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"DeFilippis AP, Blaha MJ, Martin SS, Reed RM, Jones SR, Nasir K, et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2013; 227(2): 429-36.;","DOI":"10.1016\/j.atherosclerosis.2013.01.022"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Loria P, Marchesini G, Nascimbeni F, Ballestri S, Maurantonio M, Carubbi F, et al. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 2014; 232(1): 99-109.;","DOI":"10.1016\/j.atherosclerosis.2013.10.030"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007; 45(6): 1366-74.;","DOI":"10.1002\/hep.21655"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37(4): 909-16.;","DOI":"10.1053\/jhep.2003.50132"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Yasutake K, Kohjima M, Kotoh K, Nakashima M, Nakamuta M, Enjoji M. Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(7): 1756-67.;","DOI":"10.3748\/wjg.v20.i7.1756"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scandinavian Journal of Gastroenterology 2009; 44(4): 471-7.;","DOI":"10.1080\/00365520802588133"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends in endocrinology and metabolism: TEM 2011; 22(9): 353-63.;","DOI":"10.1016\/j.tem.2011.04.007"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Privitera G, Spadaro L, Marchisello S, Fede G, Purrello F. Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance. Digestive Diseases and Sciences 2018; 63(1): 16-26.;","DOI":"10.1007\/s10620-017-4862-x"},{"key":"ref26","unstructured":"Tietge UJ, Boker KH, Bahr MJ, Weinberg S, Pichlmayr R, Schmidt HH, et al. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepato-gastroenterology 1998; 45(24): 2255-60.;"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, Molleston J, et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 2008; 135(6): 1961-71 e2.;","DOI":"10.1053\/j.gastro.2008.08.050"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Shimada M, Hashimoto E, Kaneda H, Noguchi S, Hayashi N. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatology Research: The Official Journal of the Japan Society of Hepatology 2002; 24(4): 429-38.;","DOI":"10.1016\/S1386-6346(02)00246-2"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Klini\u010dki zna\u010daj lipidnog panela i aminotransferaza u odnosu na hepati\u010dnu steatozu i fibrozu mereno kratkotrajnom elastografijom (FibroScan\u00ae)"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/24689\/15352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2021\/1452-82582101060C.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T15:31:16Z","timestamp":1611675076000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582101060C"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-24689","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}